Vitrolife AB (publ) (STO: VITR)
Sweden
· Delayed Price · Currency is SEK 215.60
+1.60 (0.75%)
Nov 19, 2024, 2:11 PM CET
Vitrolife AB Revenue
Vitrolife AB had revenue of 867.00M SEK in the quarter ending September 30, 2024, with 2.24% growth. This brings the company's revenue in the last twelve months to 3.56B, up 2.69% year-over-year. In the year 2023, Vitrolife AB had annual revenue of 3.51B with 8.60% growth.
Revenue (ttm)
3.56B
Revenue Growth
+2.69%
P/S Ratio
8.15
Revenue / Employee
3.20M
Employees
1,123
Market Cap
28.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.51B | 278.00M | 8.60% |
| Dec 31, 2022 | 3.23B | 1.55B | 92.39% |
| Dec 31, 2021 | 1.68B | 435.43M | 34.96% |
| Dec 31, 2020 | 1.25B | -234.56M | -15.85% |
| Dec 31, 2019 | 1.48B | 328.78M | 28.56% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 18.12B |
| Bonesupport Holding AB (publ) | 814.46M |